- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Pulmonary arterial hypertension
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 406KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 64KB)
Tadalafil – March 2024
Tadalafil: Tablet 20 mg; Tadalis
Last updated
30 May 2025